Nanoscale radiotherapy with hafnium oxide nanoparticles
- PMID: 23030491
- DOI: 10.2217/fon.12.96
Nanoscale radiotherapy with hafnium oxide nanoparticles
Abstract
Aim: There is considerable interest in approaches that could improve the therapeutic window of radiotherapy. In this study, hafnium oxide nanoparticles were designed that concentrate in tumor cells to achieve intracellular high-energy dose deposit.
Materials & methods: Conventional methods were used, implemented in different ways, to explore interactions of these high-atomic-number nanoparticles and ionizing radiation with biological systems.
Results: Using the Monte Carlo simulation, these nanoparticles, when exposed to high-energy photons, were shown to demonstrate an approximately ninefold radiation dose enhancement compared with water. Importantly, the nanoparticles show satisfactory dispersion and persistence within the tumor and they form clusters in the cytoplasm of cancer cells. Marked antitumor activity is demonstrated in human cancer models. Safety is similar in treated and control animals as demonstrated by a broad program of toxicology evaluation.
Conclusion: These findings, supported by good tolerance, provide the basis for developing this new type of nanoparticle as a promising anticancer approach in human patients.
Similar articles
-
[Doubling complete histological response in sarcomas with radiation therapy using nanoparticles (Hafnium oxide, NBTXR3), a phase III trial].Bull Cancer. 2019 Dec;106(12):1070-1072. doi: 10.1016/j.bulcan.2019.10.002. Epub 2019 Nov 21. Bull Cancer. 2019. PMID: 31761268 French. No abstract available.
-
NBTXR3 Radiotherapy-Activated Functionalized Hafnium Oxide Nanoparticles Show Efficient Antitumor Effects Across a Large Panel of Human Cancer Models.Int J Nanomedicine. 2021 Apr 12;16:2761-2773. doi: 10.2147/IJN.S301182. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33880022 Free PMC article.
-
Hafnium oxide nanoparticles: toward an in vitro predictive biological effect?Radiat Oncol. 2014 Jun 30;9:150. doi: 10.1186/1748-717X-9-150. Radiat Oncol. 2014. PMID: 24981953 Free PMC article.
-
New use of metals as nanosized radioenhancers.Anticancer Res. 2014 Jan;34(1):443-53. Anticancer Res. 2014. PMID: 24403500 Review.
-
Nanoparticle radio-enhancement: principles, progress and application to cancer treatment.Phys Med Biol. 2018 Jan 9;63(2):02TR01. doi: 10.1088/1361-6560/aa99ce. Phys Med Biol. 2018. PMID: 29125831 Review.
Cited by
-
NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model.Front Immunol. 2022 Nov 3;13:1022011. doi: 10.3389/fimmu.2022.1022011. eCollection 2022. Front Immunol. 2022. PMID: 36405757 Free PMC article.
-
Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers.Cells. 2020 Jul 27;9(8):1788. doi: 10.3390/cells9081788. Cells. 2020. PMID: 32727072 Free PMC article.
-
Clinical Translation of Nanomedicine.Chem Rev. 2015 Oct 14;115(19):11147-90. doi: 10.1021/acs.chemrev.5b00116. Epub 2015 Jun 19. Chem Rev. 2015. PMID: 26088284 Free PMC article. Review.
-
Nanotechnology in Radiation Oncology.Hematol Oncol Clin North Am. 2019 Dec;33(6):1071-1093. doi: 10.1016/j.hoc.2019.08.002. Epub 2019 Oct 1. Hematol Oncol Clin North Am. 2019. PMID: 31668207 Free PMC article. Review.
-
Radiation nanosensitizers in cancer therapy-From preclinical discoveries to the outcomes of early clinical trials.Bioeng Transl Med. 2021 Sep 23;7(1):e10256. doi: 10.1002/btm2.10256. eCollection 2022 Jan. Bioeng Transl Med. 2021. PMID: 35079631 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
